PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 26, 2026Vaccine0 citationsOpen Access

Improving Tdap vaccine uptake during pregnancy: a five-year analysis at a regional center

View Full Paper
NBNicole V. Perry BryceMAMaria De L. Marrero ArochoDSDara Seybold

Key Points

  • This research aims to evaluate Tdap vaccination rates among pregnant patients over a five-year period while identifying factors influencing vaccine uptake.
  • Retrospective cohort study conducted at a single tertiary-care medical center from January 11, 2019, to June 30, 2024.
  • Analyzed vaccination rates among pregnant patients categorized into pre-COVID-19, during-COVID-19, and post-COVID-19 cohorts.
  • Used ANOVA and bivariate analyses to identify demographic and clinical factors associated with Tdap receipt.
  • Among 2513 patients, 1705 (67.8%) received Tdap vaccination, higher than the national average of 56.6%.
  • Vaccination rates remained stable across all phases of the COVID-19 pandemic (p = .97).
  • Significant differences in vaccination rates were observed based on marital status (p = .016), race (p = .011), and care setting (p < .001).

Abstract

OBJECTIVE: To evaluate tetanus, diphtheria, and acellular pertussis (Tdap) vaccination rates among pregnant patients before, during, and after the COVID-19 pandemic and identify demographic and care-related factors associated with vaccine uptake at our tertiary-care medical center in Southern West Virginia. METHODS: We conducted a retrospective cohort study of pregnant patients age 18 years or older with viable pregnancies through 36 weeks of gestation from January 11, 2019, to June 30, 2024 at a single tertiary-care medical center. Patients were categorized into pre-COVID-19, during-COVID-19, and post-COVID-19 cohorts. Vaccination uptake was analyzed using ANOVA, and additional bivariate analyses were conducted to identify demographic and clinical factors associated with Tdap receipt during pregnancy. RESULTS: Among 2513 patients, 1705 (67.8%) received Tdap vaccination, which was higher than the national average of 56.6% in 2022-2023. Vaccination rates did not differ across 3 different phases relative to the COVID-19 pandemic (p = .97). Tdap vaccination was more common among patients who were married as compared with unmarried patients (70.4% vs 65.8%, p = .016), white versus non-white patients (68.9% vs 62.5%, p = .011), and patients receiving care in private-practice-based clinics versus hospital-based clinics (76.6% vs 65.6%, p < .001). No statistically significant difference was noted when stratified by insurance type (p = .24) or advanced maternal age (≥35 years) (p = .35). CONCLUSION: Tdap vaccination rates at our institution exceeded national averages and remained stable throughout the COVID-19 pandemic. Persistent disparities by race, marital status, and care setting highlight vaccination inequities and support the need for targeted interventions for patient and provider sub-groups.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bryce et al. (2026) studied this question.

synapsesocial.com/papers/6a153950b5d9c58d83e8cbcahttps://doi.org/10.1016/j.vaccine.2026.128709
Ask AI
Helpful
Bookmark
Share
View Full Paper